Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-067164
Filing Date
2025-03-28
Accepted
2025-03-28 16:33:30
Documents
15
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 PRE 14A d794651dpre14a.htm   iXBRL PRE 14A 453527
3 GRAPHIC g794651g01a03.jpg GRAPHIC 148248
4 GRAPHIC g794651g01a04.jpg GRAPHIC 179255
5 GRAPHIC g794651g89a99.jpg GRAPHIC 38454
  Complete submission text file 0001193125-25-067164.txt   1675187

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vor-20241231.xsd EX-101.SCH 2487
17 EXTRACTED XBRL INSTANCE DOCUMENT d794651dpre14a_htm.xml XML 1240
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39979 | Film No.: 25786933
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)